| Differential inhibition of mucin-type O-glycosylation (MTOG) induced by peracetyl N-thioglycolyl-d-galactosamine (Ac5GalNTGc) in myeloid cells V Dwivedi, P Saini, A Tasneem, K Agarwal, SG Sampathkumar Biochemical and biophysical research communications 506 (1), 60-65, 2018 | 6 | 2018 |
| Siglec-9 restrains antibody-dependent natural killer cell cytotoxicity against SARS-CoV-2 P Saini, OS Adeniji, D Bordoloi, J Kinslow, J Martinson, DM Parent, ... MBio 14 (1), e03393-22, 2023 | 5 | 2023 |
| Inhibitory Siglec-sialic acid interactions in balancing immunological activation and tolerance during viral infections P Saini, OS Adeniji, M Abdel-Mohsen EBioMedicine 86, 2022 | 5 | 2022 |
| Nanotechnology-based theranostic and prophylactic approaches against SARS-CoV-2 A Dhar, SL Gupta, P Saini, K Sinha, A Khandelwal, R Tyagi, A Singh, ... Immunologic Research 72 (1), 14-33, 2024 | 2 | 2024 |
| Targeting branched N-glycans and fucosylation sensitizes ovarian tumors to immune checkpoint blockade H Nie, P Saini, T Miyamoto, L Liao, RJ Zielinski, H Liu, W Zhou, C Wang, ... Nature communications 15 (1), 2853, 2024 | 1 | 2024 |
| Abstract B076: Targeting cancer glycomes sensitizes ovarian tumors to immunotherapy H Nie, P Saini, H Liu, W Zhou, C Wang, D Claiborne, N Zhang, ... Cancer Research 84 (5_Supplement_2), B076-B076, 2024 | | 2024 |
| Inhibition of mucin type O-glycosylation by N-thioglycolyl-D-galactosamine affects lateral mobility of CD43 and formation of immune synapse P Saini, A Tasneem, M Garg, N Perumal, S Sampathkumar GLYCOBIOLOGY 28 (12), 1058-1058, 2018 | | 2018 |
| Differential inhibition of mucin-type O-glycosylation (MTOG) induced by peracetyl N-thioglycolyl-D-galactosamine (Ac5GalNTGc) in myeloid cells SG Sampathkumar, P Saini, V Dwivedi, K Agarwal, A Tasneem Elsevier Inc., 2018 | | 2018 |
Srinivasa-Gopalan SampathkumarNational Institute of ImmunologyVerified email at nii.ac.in
